Pantoprazol Teva (Pantoprazole Sodium)

Pantoprazol Teva is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions:

• Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining.
• Erosive oesophagitis: heals erosions caused by chronic acid exposure.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls excessive gastric acid production.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

• Pantoprazole sodium inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells in the stomach. By binding irreversibly to this pump, it blocks the final step of acid secretion, leading to a sustained reduction in gastric acidity and providing an environment conducive to mucosal healing.

Pantoprazol Teva may cause a range of adverse reactions. The profile includes both frequent, mild events and rarer, potentially serious conditions.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain: mild discomfort.
• Flatulence: increased intestinal gas.
• Constipation: occasional bowel habit change.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis risk.
• Acute interstitial nephritis: kidney inflammation.
• Severe allergic reactions: rash, swelling, anaphylaxis.
• Low magnesium levels: may cause muscle cramps or arrhythmia.
• Bone fractures: increased risk with long‑term use.
• Liver enzyme elevation: potential hepatic impact.

When prescribing Pantoprazol Teva, clinicians should consider several safety aspects:

• Assess renal function: dose adjustment may be needed in severe impairment.
• Monitor magnesium levels: long‑term therapy can cause hypomagnesemia.
• Evaluate bone health: prolonged use may affect calcium absorption.
• Review concomitant medications: potential for altered absorption of drugs requiring acidic pH.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazol Teva can affect the pharmacokinetics of several co‑administered medicines. Awareness of these interactions helps maintain therapeutic efficacy.

Major Interactions (Avoid)

• Antifungal agents (ketoconazole, itraconazole): markedly reduced absorption.
• HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations.
• Clopidogrel: reduced antiplatelet effect, consider alternative therapy.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR, monitor coagulation.
• Methotrexate: reduced renal clearance, watch for toxicity.
• Digoxin: slight increase in serum levels, assess cardiac status.
• Oral contraceptives: may lower efficacy, advise backup method.